| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antihypertensive medication use and incident breast cancer in women
|
Devore, Elizabeth E.
|
|
2015
|
150 |
1 |
p. 219-229
|
artikel
|
| 2 |
Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies
|
Zhong, Shanliang
|
|
2015
|
150 |
1 |
p. 199-207
|
artikel
|
| 3 |
Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists
|
Erin, Nuray
|
|
2015
|
150 |
1 |
p. 57-69
|
artikel
|
| 4 |
Bcl-2 is a highly significant prognostic marker of hormone-receptor-positive, human epidermal growth factor receptor-2-negative breast cancer
|
Seong, Min-Ki
|
|
2015
|
150 |
1 |
p. 141-148
|
artikel
|
| 5 |
Cancer stem cell and epithelial–mesenchymal transition markers predict worse outcome in metaplastic carcinoma of the breast
|
Oon, Ming Liang
|
|
2015
|
150 |
1 |
p. 31-41
|
artikel
|
| 6 |
Contralateral breast cancer risk in relation to tumor morphology and age—in which patients is preoperative MRI justified?
|
Glas, N. A. de
|
|
2015
|
150 |
1 |
p. 191-198
|
artikel
|
| 7 |
Cost-effectiveness of prophylactic granulocyte colony-stimulating factor for febrile neutropenia in breast cancer patients receiving FEC-D
|
Lee, Esther K.
|
|
2015
|
150 |
1 |
p. 169-180
|
artikel
|
| 8 |
DNA damage response markers are differentially expressed in BRCA-mutated breast cancers
|
Aleskandarany, Mohammed
|
|
2015
|
150 |
1 |
p. 81-90
|
artikel
|
| 9 |
Evidence for biological effects of metformin in operable breast cancer: biomarker analysis in a pre-operative window of opportunity randomized trial
|
Hadad, Sirwan M.
|
|
2015
|
150 |
1 |
p. 149-155
|
artikel
|
| 10 |
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials
|
Fontanella, Caterina
|
|
2015
|
150 |
1 |
p. 127-139
|
artikel
|
| 11 |
Mammographic breast density and breast cancer risk: interactions of percent density, absolute dense, and non-dense areas with breast cancer risk factors
|
Yaghjyan, Lusine
|
|
2015
|
150 |
1 |
p. 181-189
|
artikel
|
| 12 |
Prevalence of BRCA1 and BRCA2 germline mutations in patients with triple-negative breast cancer
|
Wong-Brown, Michelle W.
|
|
2015
|
150 |
1 |
p. 71-80
|
artikel
|
| 13 |
Prognostic significance of epithelial–mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast
|
Lim, Jeffrey Chun Tatt
|
|
2015
|
150 |
1 |
p. 19-29
|
artikel
|
| 14 |
Rationale for targeting fibroblast growth factor receptor signaling in breast cancer
|
André, Fabrice
|
|
2015
|
150 |
1 |
p. 1-8
|
artikel
|
| 15 |
Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy
|
Acevedo-Gadea, Carlos
|
|
|
150 |
1 |
p. 157-167
|
artikel
|
| 16 |
Sirolimus and trastuzumab combination therapy for HER2-positive metastatic breast cancer after progression on prior trastuzumab therapy
|
Acevedo-Gadea, Carlos
|
|
2015
|
150 |
1 |
p. 157-167
|
artikel
|
| 17 |
Targeting metabolic plasticity in breast cancer cells via mitochondrial complex I modulation
|
Xu, Qijin
|
|
2015
|
150 |
1 |
p. 43-56
|
artikel
|
| 18 |
T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer
|
Kong, De-di
|
|
2015
|
150 |
1 |
p. 119-126
|
artikel
|
| 19 |
The mammalian target of rapamycin complex 1 (mTORC1) in breast cancer: the impact of oestrogen receptor and HER2 pathways
|
Jerjees, Dena A.
|
|
2015
|
150 |
1 |
p. 91-103
|
artikel
|
| 20 |
The 3′UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1
|
Zheng, Lufeng
|
|
2015
|
150 |
1 |
p. 105-118
|
artikel
|
| 21 |
Tyrosine kinase discoidin domain receptors DDR1 and DDR2 are coordinately deregulated in triple-negative breast cancer
|
Toy, Kathy A.
|
|
2015
|
150 |
1 |
p. 9-18
|
artikel
|
| 22 |
Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer
|
Aogi, Kenjiro
|
|
2015
|
150 |
1 |
p. 209-217
|
artikel
|
Tijdschrift beschrijving